Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-037779
Filing Date
2020-08-06
Accepted
2020-08-06 16:21:57
Documents
83
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q qtnt-10q_20200630.htm   iXBRL 10-Q 2433321
2 EX-31.1 qtnt-ex311_9.htm EX-31.1 16378
3 EX-31.2 qtnt-ex312_6.htm EX-31.2 16438
4 EX-32.1 qtnt-ex321_8.htm EX-32.1 5127
5 EX-32.2 qtnt-ex322_7.htm EX-32.2 5129
  Complete submission text file 0001564590-20-037779.txt   10119088

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA qtnt-20200630.xsd EX-101.SCH 62834
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE qtnt-20200630_cal.xml EX-101.CAL 87422
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE qtnt-20200630_def.xml EX-101.DEF 187892
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE qtnt-20200630_lab.xml EX-101.LAB 506099
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qtnt-20200630_pre.xml EX-101.PRE 395214
11 EXTRACTED XBRL INSTANCE DOCUMENT qtnt-10q_20200630_htm.xml XML 2121095
Mailing Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA
Business Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA 41274832286
Quotient Ltd (Filer) CIK: 0001596946 (see all company filings)

EIN.: 264719797 | State of Incorp.: Y9 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-36415 | Film No.: 201082034
SIC: 2835 In Vitro & In Vivo Diagnostic Substances